To evaluate the effect of Ranolazine on Fasting Plasma Glucose in patients of Type II Diabetes Mellitus with Stable Angina as add on therapy
DOI:
https://doi.org/10.7439/ijbar.v4i10.508Abstract
Objective: The study was aimed to evaluate the effect of Ranolazine on Fasting Plasma Glucose (FPG) in patients of Type II Diabetes Mellitus with Stable Angina as add on therapy. Material and Methods: An open-labeled, randomized, controlled parallel group study was conducted in 76 diagnosed patients of Type II Diabetes Mellitus with Stable Angina at S.N. medical College and Hospital, Agra. The selected patients randomly assigned into 2 groups, Control group (Group 1): was on their regular therapy during the 8-week study period. Test group (Group 2): was on Ranolazine 500mg BD (orally) in addition to their regular therapy during the 8week study period. The FPG measurement was done at baseline, repeated after 4weeks and at the end of treatment (i.e at 8week). All data obtained were expressed as meanDownloads
Download data is not yet available.
Downloads
Published
2013-10-30
Issue
Section
Original Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
To evaluate the effect of Ranolazine on Fasting Plasma Glucose in patients of Type II Diabetes Mellitus with Stable Angina as add on therapy. (2013). International Journal of Biomedical and Advance Research, 4(10), 690-694. https://doi.org/10.7439/ijbar.v4i10.508
